News
INNPF
1.700
NaN%
--
Weekly Report: what happened at INNPF last week (0622-0626)?
Weekly Report · 2d ago
Weekly Report: what happened at INNPF last week (0615-0619)?
Weekly Report · 06/22 10:37
Weekly Report: what happened at INNPF last week (0608-0612)?
Weekly Report · 06/15 10:37
Weekly Report: what happened at INNPF last week (0601-0605)?
Weekly Report · 06/08 10:32
Weekly Report: what happened at INNPF last week (0525-0529)?
Weekly Report · 06/01 10:38
Innocan Pharma reports Q1 results
Seeking Alpha · 05/27 20:29
Weekly Report: what happened at INNPF last week (0518-0522)?
Weekly Report · 05/25 10:42
Weekly Report: what happened at INNPF last week (0511-0515)?
Weekly Report · 05/18 10:41
Weekly Report: what happened at INNPF last week (0504-0508)?
Weekly Report · 05/11 10:38
Weekly Report: what happened at INNPF last week (0427-0501)?
Weekly Report · 05/04 10:34
Weekly Report: what happened at INNPF last week (0420-0424)?
Weekly Report · 04/27 10:38
Weekly Report: what happened at INNPF last week (0413-0417)?
Weekly Report · 04/20 10:33
Weekly Report: what happened at INNPF last week (0406-0410)?
Weekly Report · 04/13 10:38
Innocan Pharma Secures Additional Insider Debenture Ahead of Planned U.S. Offering
TipRanks · 04/06 13:26
Weekly Report: what happened at INNPF last week (0330-0403)?
Weekly Report · 04/06 10:38
Innocan Pharma reports FY results
Seeking Alpha · 04/02 18:07
Innocan Pharma Secures Additional Insider Debenture Financing Ahead of Planned U.S. Offering
TipRanks · 03/31 22:15
Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M
PR Newswire · 03/31 07:00
Weekly Report: what happened at INNPF last week (0323-0327)?
Weekly Report · 03/30 10:39
Weekly Report: what happened at INNPF last week (0316-0320)?
Weekly Report · 03/23 10:34
More
Webull provides a variety of real-time INNPF stock news. You can receive the latest news about Innocan Pharma through multiple platforms. This information may help you make smarter investment decisions.
About INNPF
Innocan Pharma Corporation is an Israel-based company active in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, the Company aims to provide a safe, non-opioid chronic pain management solutions for both animals and humans. To achieve this aim, the Company developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management. In the wellness sector, the Company develops and markets a wide portfolio of high-performance self-care and beauty products to promote a healthier lifestyle. Under this segment Innocan established a Joint Venture (BI Sky Global Ltd.) that focused on advanced, targeted online sales.